MedTrace Logo

Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort

NCT06078527 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-07-23

No results posted yet for this study

Summary

A previous study completed in 2022 (NCT05158179) was conducted using cohorts of healthy controls, and adults with general laryngopharyngeal disorders. This study will expand on the previous research to include a separate cohort of adults being seen in clinic for an existing laryngopharyngeal disorder resulting from previous radiation or other cancer treatments.

Conditions

  • Presbylarynx
  • Aspiration
  • Spasmodic Dysphonia
  • Globus Pharyngeus
  • Larynx Paralysis
  • Laryngeal Disease
  • Vocal Cord Paralysis
  • Iatrogenic Injury
  • Sensory Neuropathy

Interventions

DEVICE

Cheung-Bearelly Aesthesiometer

The Cheung-Bearelly Aesthesiometer will be used to deliver a range of calibrated stimuli through the channeled flexible laryngoscope to assess sensation of the laryngopharynx.

PROCEDURE

Transnasal Laryngoscopy

A procedure to examine your larynx (voice box)

OTHER

Questionnaires

Patient-reported health and behavioral outcomes measures will be administered

Sponsors & Collaborators

Principal Investigators

  • Yue Ma, MD · University of California, San Francisco

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2028-01-31
Completion
2028-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06078527 on ClinicalTrials.gov